Literature DB >> 29181728

Comparison of composite indices with global synovitis score on ultrasound for detecting remission.

Merve Ozata Olmez1, Esen Kasapoglu Gunal2, Sibel Bakirci Ureyen3, Havva Keskin2, Ayse Bilge Ozturk4, Gokce Yeter5, Erim Cobanoglu5, Sibel Zehra Aydin6.   

Abstract

We aimed to compare composite indices with Ultrasound Global Synovitis Score (GLOESS) for remission in rheumatoid arthritis (RA). RA patients in remission according to the clinician were investigated with Disease Activity Score28 (DAS28), Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI), and RAPID-3 (Routine Assessment of Patient Index Data 3). Ultrasonography was performed using the GLOESS scores. Patients in CDAI-remission had lower GLOESS (median (IQR), 5(3-9.75) vs 7(4-11.75), p = 0.048) with a similar trend in SDAI (5(3-9.25) vs 7(4-11.25), p = 0.064). This was not observed with DAS28-CRP and RAPID3. Our results show that CDAI is superior to other indices to assess remission in RA.

Entities:  

Keywords:  CDAI; RAPID3; Remission; Rheumatoid arthritis; SDAI; US-GLOESS

Mesh:

Substances:

Year:  2017        PMID: 29181728     DOI: 10.1007/s10067-017-3925-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  3 in total

1.  Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.

Authors:  Lene Terslev; Cecilie Heegaard Brahe; Mikkel Østergaard; Viktoria Fana; Mads Ammitzbøll-Danielsen; Torsten Møller; Simon Krabbe; Merete Lund Hetland; Uffe Møller Døhn
Journal:  Arthritis Res Ther       Date:  2021-02-01       Impact factor: 5.156

2.  Ultrasound response to tofacitinib in patients with rheumatoid arthritis: Data from a multicenter 24 weeks prospective study.

Authors:  Giuseppe Germanò; Pierluigi Macchioni; Beatrice Maranini; Giovanni Ciancio; Sara Bonazza; Marcello Govoni; Carlo Salvarani
Journal:  Front Med (Lausanne)       Date:  2022-09-26

3.  Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.

Authors:  Isabela Araújo Santos; Renê Donizeti Ribeiro de Oliveira; Sergio Couto Luna Almeida; Ana Beatriz Vargas-Santos; Rodrigo Balbino Chaves Amorim; Ana Paula Monteiro Gomides; Cleandro Pires de Albuquerque; Manoel Barros Bertolo; Maria Fernanda Brandão Resende Guimarães; Maria Raquel da Costa Pinto; Gustavo Gomes Resende; Rina Dalva Neubarth Giorgi; Nathalia de Carvalho Saciloto; Sebastião Cezar Radominski; Fernanda Maria Borghi; Karina Rossi Bonfiglioli; Henrique Carrico da Silva; Maria de Fatima L da Cunha Sauma; Ivanio Alves Pereira; Glaucio Ricardo Werner de Castro; Claiton Viegas Brenol; Ricardo Machado Xavier; Licia Maria Henrique Mota; Paulo Louzada-Junior; Geraldo da Rocha Castelar-Pinheiro
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.